Oligometastasis is a metastatic disease that is limited by number and organ sites. Definitions have been heterogeneous, and thus meaningful interpretation of available data in this subject matter remains challenging. The incidence is definitely increasing with improved access to imaging modalities as well as the technologies related to imaging.
This talk will focus on case-based approach to management oligometastatic disease. In the process, available evidences to support such management recommendations will also be explored.